Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0002083206-26-000002

Chief Financial Officer acquired 44,665 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tamayo Louis Edward Chief Financial Officer 2026-02-04 Grant or award +44,665 89,665 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Tamayo Louis Edward Chief Financial Officer 2026-02-04 Grant or award · Stock Option (right to buy) +226,665 226,665 D: show line 2 in the form
Loading xslF345X05/form4-02062026_050201.xml…